The drug efflux–metabolism alliance: biochemical aspects
- 1 October 2001
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 50, S3-S11
- https://doi.org/10.1016/s0169-409x(01)00178-8
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The Gut as a Barrier to Drug AbsorptionClinical Pharmacokinetics, 2001
- The role of intestinal P-glycoprotein in the interaction of digoxin and rifampinJournal of Clinical Investigation, 1999
- Role of P-Glycoprotein and Cytochrome P450 3A in Limiting Oral Absorption of Peptides and Peptidomimetics†Journal of Pharmaceutical Sciences, 1998
- The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.Journal of Clinical Investigation, 1998
- Active secretion and enterocytic drug metabolism barriers to drug absorptionAdvanced Drug Delivery Reviews, 1996
- Intestinal drug metabolism and antitransport processes: A potential paradigm shift in oral drug deliveryJournal of Controlled Release, 1996
- Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cellsEndocrinology, 1993
- Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes.Journal of Clinical Investigation, 1992
- Effect of Food on the Pharmacokinetics of Cyclosporine in Healthy Subjects Following Oral and Intravenous AdministrationThe Journal of Clinical Pharmacology, 1990
- Absorption kinetics of cyclosporine in healthy volunteersBiopharmaceutics & Drug Disposition, 1989